Successful weaning from 65-day extracorporeal membrane oxygenation therapy in influenza-associated acute respiratory distress syndrome

International Journal of Artificial Organs

Volumn 39, Issue 5, 2016, Pages 249-252

  Buchtele, Nina ^a   Schellongowski, Peter ^a   Bojic, Andja ^a   Hermann, Alexander ^a   Robak, Oliver ^a   Lamm, Wolfgang ^a   Staudinger, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Active physical therapy; ARDS; Extracorporeal membrane oxygenation; H1N1; Influenza; Prolonged ECMO

Indexed keywords

OXYGENATION; PHYSICAL THERAPY; VIRUSES;

ACTIVE PHYSICAL THERAPY; ACUTE RESPIRATORY DISTRESS SYNDROME; ADDITIONAL TREATMENT; CASE REPORTS; EXTRACORPOREAL MEMBRANE OXYGENATION; H1N1 INFLUENZA VIRUS; INFLUENZA; PROLONGED EXTRACORPOREAL MEMBRANE OXYGENATION; TREATMENT MEASURES;

RESPIRATORY THERAPY;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; EXTRACORPOREAL OXYGENATION; HYPOXEMIA; INFLUENZA; PHYSIOTHERAPY; PLEURA EFFUSION; REAL TIME POLYMERASE CHAIN REACTION; WEANING; COMPLICATION; EXHALATION; HUMAN; INFLUENZA A VIRUS (H1N1); MALE; MIDDLE AGED; SEVERE ACUTE RESPIRATORY SYNDROME; TREATMENT OUTCOME;

EXHALATION; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SEVERE ACUTE RESPIRATORY SYNDROME; TREATMENT OUTCOME;

EID: 84979088383     PISSN: 03913988     EISSN: 17246040     Source Type: Journal    
DOI: 10.5301/ijao.5000501     Document Type: Article

References (17)

1. Zangrillo A, Biondi-Zoccai G, Landoni G, et al. Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care. 2013;17(1):R30.
2. Australia, New Zealand Extracorporeal Membrane Oxygenation Influenza Investigators, Davies A, Jones D, Bailey M, et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA. 2009;302(17): 1888-1895.
3. Extracorporeal Life Support Organization. H1N1 Registry available at http://www.elso.org/Registry/H1N1Registry.aspx. Accessed May 10, 2016.
4. Otterspoor LC, Smit FH, van Laar TJ, Kesecioglu J, van Dijk D. Prolonged use of extracorporeal membrane oxygenation combined with prone positioning in patients with acute respiratory distress syndrome and invasive Aspergillosis. Perfusion. 2012;27(4): 335-337.
5. Peek GJ, Mugford M, Tiruvoipati R, et al; CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351-1363.
6. Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med. 2009;35(12):2105-2114.
7. Lindskov C, Jensen RH, Sprogoe P, et al. Extracorporeal membrane oxygenation in adult patients with severe acute respiratory failure. Acta Anaesthesiol Scand. 2013;57(3):303-311.
8. Moon SM, Lee H, Moon JH, et al. Prolonged Maintenance of VV ECMO for 104 days with Native Lung Recovery in Acute Respiratory Failure: A Case Report. ASAIO J. 201;62(2):315-e17.
9. Wiktor AJ, Haft JW, Bartlett RH, Park PK, Raghavendran K, Napolitano LM. Prolonged VV ECMO (265 Days) for ARDS without technical complications. ASAIO J. 2015;61(2):205-206.
10. Needham DM. Mobilizing patients in the intensive care unit: improving neuromuscular weakness and physical function. JAMA. 2008;300(14):1685-1690.
11. Abrams D, Javidfar J, Farrand E, et al. Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study. Crit Care. 2014;18(1):R38.
12. Schmidt M, Zogheib E, Rozé H, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med. 2013;39(10):1704-1713.
13. Schmidt M, Bailey M, Sheldrake J, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med. 2014;189(11):1374-1382.
14. Enger T, Philipp A, Videm V, et al. Prediction of mortality in adult patients with severe acute lung failure receiving venovenous extracorporeal membrane oxygenation: a prospective observational study. Crit Care. 2014;18(2):R67.
15. Bein T, Weber-Carstens S, Herridge M. Extracorporeal life support, ethics, and questions at the bedside: how does the end of the pathway look? Intensive Care Med. 2015;41(9):1714-1715.
16. Coudroy R, Jamet A, Peñuelas O, Thille AW. Use of Type III procollagen measurement as predictor of lung fibroproliferation in ARDS: early measurement for earlier antifibroproliferative therapy? Intensive Care Med. 2015;41(6):1159-1160.
17. Donati SY, Papazian L. Role of open-lung biopsy in acute respiratory distress syndrome. Curr Opin Crit Care. 2008;14(1):75-79.